about
Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary studyAfatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer ConsortiumComputer-Aided Diagnosis with Deep Learning Architecture: Applications to Breast Lesions in US Images and Pulmonary Nodules in CT ScansQuantitative ultrasound analysis for classification of BI-RADS category 3 breast masses.Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer.Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapyPolymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerComparative study of density analysis using automated whole breast ultrasound and MRILow penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association ConsortiumDeregulated microRNAs in triple-negative breast cancer revealed by deep sequencingGenetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.A novel 96well-formatted micro-gap plate enabling drug response profiling on primary tumour samples.High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country.Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast CancerCommon genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls.TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancerCYP19 genetic polymorphism haplotype AASA is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer.Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast--a review of 42 primary and secondary cases in Taiwanese patients.Automatic Marker-free Longitudinal Infrared Image Registration by Shape Context Based Matching and Competitive Winner-guided Optimal Corresponding.Computer-aided US diagnosis of breast lesions by using cell-based contour grouping.Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.Computer-aided multiview tumor detection for automated whole breast ultrasound.Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?Quantitative analysis of breast echotexture patterns in automated breast ultrasound images.Intensity-Invariant Texture Analysis for Classification of BI-RADS Category 3 Breast Masses.Tumor detection in automated breast ultrasound images using quantitative tissue clustering.Quantitative analysis for breast density estimation in low dose chest CT scans.Automatic detection of microcalcifications in breast ultrasound.Rapid breast density analysis of partial volumes of automated breast ultrasound images.Computer-aided diagnosis of breast masses using quantified BI-RADS findings.
P50
Q24625216-769D9AE0-E97A-4DD4-8EEC-8622FB40330BQ27853332-5D0CCBAB-98C2-438D-9A5A-56BDF32EDFE0Q28474694-A29665E5-2A23-45CF-B302-D892D232BBDEQ30385578-AB8156D9-9279-4A34-83FE-6FE2C9F08B09Q30424166-94FCFBDC-2743-45F3-B908-6AEB0865F066Q30758991-FC51391E-6564-4982-918B-332D2639A4B2Q31036814-C25209BD-863D-496E-A265-E51F0F862B1BQ33206939-D82E0690-4657-4264-897C-CB39A1C324D9Q33391344-13460DF8-DCEE-414D-9207-5BCAC918A64DQ33568902-C7A25138-6668-4773-AF4F-11E148AC2661Q33591401-82B7A105-BC4A-419C-BC1A-ADBBA8A52E1BQ33699658-8E045D23-36B5-4181-8ED6-E262310BA37BQ33739686-C2E7865F-6264-448C-B5AB-898CFEA193A6Q34181322-A2919D9F-AFDC-49A1-8271-6ABDA1D98598Q34493761-12A33520-7C0D-48E8-A227-37D0C3BDB158Q35119701-FE70EF1D-7CC0-4EF9-A324-823287DEA7CBQ35153783-9AFF4FC0-4136-4986-A2FA-7AB5D7325918Q35179897-6F1C3ABD-37BA-41FD-9764-3A9535000445Q35376965-C5763C14-500B-485E-8CA1-FA23A858C066Q35536735-BDFD5DB9-830C-4D6A-8C94-9F6D7B64991AQ35997372-DE4741F1-D7B9-45E4-9CB1-A60C375922B3Q36376097-23C95D96-2644-4112-AF6D-3F8F006A3393Q36579447-B74E9F7C-4CCE-4A6D-9882-B1DAB2357549Q36856357-94972AED-C301-40C5-857A-5F4A5F562C09Q36946765-DD85B683-5DEB-4550-96AC-8E4F08C079C3Q36946787-6EA7E5C4-E038-4986-A0E4-184884B60021Q37353704-B687D05D-8D4E-4831-80E5-0FE8D6B5A298Q37448357-FB7E5B24-62A8-4B35-B7C0-F7B0BF2C7121Q37618134-2DAEC0A0-8538-4B65-B696-63DD90CCB259Q37760647-888B4D40-7A2C-4CCF-8BD0-0A570E285FD1Q38059133-129058BE-0A2A-4ABB-9310-F802A6704DD6Q38166147-7A145221-4F9E-4827-9527-B7CA1645FFB6Q38409973-9A939B47-4C20-4E4D-B87E-180C55D221E0Q38423710-3FDA6929-1A2E-49B8-AE2B-D0B06E23D074Q38427294-962B8EA0-4D30-4ADD-B8A7-D04EDC3C7059Q38439714-FC74554C-DD92-4A3B-AD6E-69C817E4B362Q38440261-6769DE0A-4827-4066-BAB7-0F3BA8FB75C5Q38446464-69937594-CA8F-4D43-946B-3A8CE7A3E4D9Q38446517-1EF0831D-B648-4B76-83A3-AECEAF413AAFQ38450774-CAB17179-5F27-4CE6-AF2E-A9B15ADB86A6
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Chiun-Sheng Huang
@ast
Chiun-Sheng Huang
@en
Chiun-Sheng Huang
@es
Chiun-Sheng Huang
@nl
Chiun-Sheng Huang
@sl
type
label
Chiun-Sheng Huang
@ast
Chiun-Sheng Huang
@en
Chiun-Sheng Huang
@es
Chiun-Sheng Huang
@nl
Chiun-Sheng Huang
@sl
altLabel
Chiun-Sheng Huang
@en
黃俊升
@en
prefLabel
Chiun-Sheng Huang
@ast
Chiun-Sheng Huang
@en
Chiun-Sheng Huang
@es
Chiun-Sheng Huang
@nl
Chiun-Sheng Huang
@sl
P106
P1153
34768385900
P2456
P31
P496
0000-0002-6557-211X